Immuneering (IMRX) Short-term Investments (2021 - 2024)
Historic Short-term Investments for Immuneering (IMRX) over the last 4 years, with Q3 2024 value amounting to $5.5 million.
- Immuneering's Short-term Investments fell 8132.97% to $5.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.5 million, marking a year-over-year decrease of 8132.97%. This contributed to the annual value of $26.3 million for FY2023, which is 2015.36% down from last year.
- Immuneering's Short-term Investments amounted to $5.5 million in Q3 2024, which was down 8132.97% from $5.0 million recorded in Q1 2024.
- In the past 5 years, Immuneering's Short-term Investments registered a high of $74.3 million during Q4 2021, and its lowest value of $5.0 million during Q2 2023.
- Moreover, its 4-year median value for Short-term Investments was $31.0 million (2022), whereas its average is $31.5 million.
- As far as peak fluctuations go, Immuneering's Short-term Investments tumbled by 416.21% in 2022, and later tumbled by 8763.11% in 2023.
- Quarter analysis of 4 years shows Immuneering's Short-term Investments stood at $74.3 million in 2021, then plummeted by 55.74% to $32.9 million in 2022, then decreased by 20.15% to $26.3 million in 2023, then crashed by 79.24% to $5.5 million in 2024.
- Its last three reported values are $5.5 million in Q3 2024, $5.0 million for Q1 2024, and $26.3 million during Q4 2023.